A Ketamine-Based Nasal Spray Is Now an FDA-Approved Depression Treatment
The U.S. Food and Drug Administration hasapprovedthe first new kind of depression treatment seen in decades , a nasal spray drug based on the sedative ketamine hydrochloride . The raw drug , licence by Johnson & Johnson ’s pharma division , Janssen Pharmaceuticals , is n’t ketamine on the button . It ’s derived from esketamine , a chemical sibling of ketamine . It will be sell under the firebrand name Spravato ....